Skip to Content

MTB SUSCEPTIBILITY-PYRAZINAMIDE (SDL11944)

https://www.scanlabglobal.com/web/image/product.template/6630/image_1920?unique=18393fc
Tests MTB susceptibility to pyrazinamide for TB therapy. Susceptibility confirms pyrazinamide efficacy in 1st-line TB regimens.

470.00 AED 470.0 AED 470.00 AED

470.00 AED

Not Available For Sale

This combination does not exist.